RNA-based therapeutics are a relatively new class of drugs based on RNA sequences. There are three main classes of RNA therapeutics: small interfering RNA (siRNA), RNA aptamers, and ribozymes. siRNA Therapeutics and Gene Expression Last year, the first siRNA-based therapeutic was approved by the FDA. The drug, called ONPATTRO® (patisiran), developed by Alnylam Pharmaceuticals, aims to treat peripheral nerve disease caused by hereditary transthyretin-mediated (hATTR) amyloidosis in... Read More